A groundbreaking study from Emory University demonstrates how psilocybin-assisted therapy could impact more than 5 million people in the U.S. pending approval from the FDA. The findings highlight both the national need for therapies featuring psilocybin, the active ingredient in hallucinogenic mushrooms, as well as the considerations that elected officials, insurance companies, and public health agencies would need to be aware of to successfully roll-out access to psilocybin-assisted therapy (PSIL-AT). 

Forming memories around shared experiences, whether something fun like grabbing a pizza or as emotionally straining as an employee strike, has a way of binding people together. But it could also motivate those performing different roles within the same company to socialize more and strengthen their working relationships, according to new research from Binghamton University, State University of New York.

Access to negotiation and conflict management education can transform lives and foster greater understanding between individuals, communities and organisations across divides.